GoodRx Holdings (GDRX) Amortization of Deferred Charges (2019 - 2026)
GoodRx Holdings recorded quarterly Amortization of Deferred Charges of $462000.0 in Q1 2026, up 1.76% quarter-over-quarter from $454000.0 in Q4 2025, and up 7.44% year-over-year from $430000.0 in Q1 2025.
GoodRx Holdings' Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $462000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 7.44% year-over-year to $462000.0; the TTM figure through Mar 2026 stood at $1.8 million (down 13.88% YoY), while the FY2025 annual figure was $1.8 million, down 29.2% from the prior year.
- Amortization of Deferred Charges came in at $462000.0 for Q1 2026 at GoodRx Holdings, up from $454000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $856000.0 in Q1 2022 to a low of $413000.0 in Q3 2024.
- A 5-year average of $677764.7 and a median of $837000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges sank 51.07% in 2024 and rose 7.84% in 2025, its largest moves.
- GoodRx Holdings' Amortization of Deferred Charges stood at $851000.0 in 2022, then fell by 0.94% to $843000.0 in 2023, then slumped by 50.06% to $421000.0 in 2024, then gained by 7.84% to $454000.0 in 2025, then grew by 1.76% to $462000.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $462000.0, $454000.0, and $445000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 462,000.00 |
| Mar 31, 2026 | 462,000.00 |
| Dec 31, 2025 | 454,000.00 |
| Dec 31, 2025 | 454,000.00 |
| Sep 30, 2025 | 445,000.00 |
| Sep 30, 2025 | 445,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 430,000.00 |
| Mar 31, 2025 | 430,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Sep 30, 2024 | 413,000.00 |
| Sep 30, 2024 | 413,000.00 |
| Jun 30, 2024 | 826,000.00 |
| Jun 30, 2024 | 826,000.00 |
| Mar 31, 2024 | 837,000.00 |
| Mar 31, 2024 | 837,000.00 |
| Dec 31, 2023 | 843,000.00 |
| Dec 31, 2023 | 843,000.00 |
| Sep 30, 2023 | 844,000.00 |
| Sep 30, 2023 | 844,000.00 |
| Jun 30, 2023 | 846,000.00 |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 849,000.00 |
| Mar 31, 2023 | 849,000.00 |
| Dec 31, 2022 | 851,000.00 |
| Dec 31, 2022 | 851,000.00 |
| Sep 30, 2022 | 852,000.00 |
| Sep 30, 2022 | 852,000.00 |
| Jun 30, 2022 | 854,000.00 |
| Jun 30, 2022 | 854,000.00 |
| Mar 31, 2022 | 856,000.00 |
| Mar 31, 2022 | 856,000.00 |
| Dec 31, 2021 | 859,000.00 |
| Dec 31, 2021 | 859,000.00 |
| Sep 30, 2021 | 859,000.00 |
| Sep 30, 2021 | 859,000.00 |
| Jun 30, 2021 | 864,000.00 |
| Jun 30, 2021 | 864,000.00 |
| Mar 31, 2021 | 863,000.00 |
| Mar 31, 2021 | 863,000.00 |
| Dec 31, 2020 | 960,000.00 |
| Dec 31, 2020 | 960,000.00 |
| Sep 30, 2020 | 834,000.00 |
| Sep 30, 2020 | 834,000.00 |
| Jun 30, 2020 | 813,000.00 |
| Jun 30, 2020 | 813,000.00 |
| Mar 31, 2020 | 783,000.00 |
| Mar 31, 2020 | 783,000.00 |
| Dec 31, 2019 | 836,000.00 |
| Dec 31, 2019 | 836,000.00 |